Genetic Markers Enhance Coronary Risk Prediction in Men: The MORGAM Prospective Cohorts

• Maria F. Hughes ,

  * E-mail: maria.hughes@qub.ac.uk

  Affiliation UKCRC Centre of Excellence for Public Health, Queens University of Belfast, Belfast, Northern Ireland, United Kingdom

  ⨯
• Olli Saarela,

  Affiliation Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland

  ⨯
• Jan Stritzke,

  Affiliation Universität zu Lübeck, Lübeck, Germany

  ⨯
• Frank Kee,

  Affiliation UKCRC Centre of Excellence for Public Health, Queens University of Belfast, Belfast, Northern Ireland, United Kingdom

  ⨯
• Kaisa Silander,

  Affiliations Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland, FIMM, Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland

  ⨯
• Norman Klopp,

  Affiliation Institute of Epidemiology II, Helmholtz Zentrum München, München, Germany

  ⨯
• Jukka Kontto,

  Affiliation Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland

  ⨯
• Juha Karvanen,

  Affiliation Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland

  ⨯
• Christina Willenborg,

  Affiliation Universität zu Lübeck, Lübeck, Germany

  ⨯
• Veikko Salomaa,

  Affiliation Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland

  ⨯
• Jarmo Virtamo,

  Affiliation Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland

  ⨯
• Phillippe Amouyel,

  Affiliation INSERM U744, Lille, France

  ⨯
• Dominique Arveiler,

  Affiliation Department of Epidemiology and Public Health, EA3430, University of Strasbourg, Strasbourg, France

  ⨯
• Jean Ferrières,

  Affiliation INSERM U558, Toulouse University School of Medicine, Toulouse, France

  ⨯
• Per-Gunner Wiklund,

  Affiliation Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden

  ⨯
• Jens Baumert,

  Affiliation Institute of Epidemiology II, Helmholtz Zentrum München, München, Germany

  ⨯
• Barbara Thorand,

  Affiliation Institute of Epidemiology II, Helmholtz Zentrum München, München, Germany

  ⨯
• Patrick Diemert,

  Affiliation Universität zu Lübeck, Lübeck, Germany

  ⨯
• David-Alexandre Trégouët,

  Affiliation INSERM UMRS937, University Pierre et Marie Currie, Paris, France

  ⨯
• Christian Hengstenberg,

  Affiliation Department of Internal Medicine and Cardiology, University of Regensburg, Regensburg, Germany

  ⨯
• Annette Peters,

  Affiliation Institute of Epidemiology II, Helmholtz Zentrum München, München, Germany

  ⨯
• Alun Evans,

  Affiliation UKCRC Centre of Excellence for Public Health, Queens University of Belfast, Belfast, Northern Ireland, United Kingdom

  ⨯
• Wolfgang Koenig,

  Affiliation Department of Internal Medicine II–Cardiology, University of Ulm, Ulm, Germany

  ⨯
• Jeanette Erdmann,

  Affiliation Universität zu Lübeck, Lübeck, Germany

  ⨯
• Nilesh J. Samani,

  Affiliation Department of Cardiovascular Sciences, University of Leicester, and Leicester NIHR Biomedical Research Unit in Cardiovascular Disease, Glenfield Hospital, Leicester, United Kingdom

  ⨯
• Kari Kuulasmaa ,

  Contributed equally to this work with: Kari Kuulasmaa, Heribert Schunkert

  Affiliation Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland

  ⨯
•  [ ... ],
• Heribert Schunkert

  Contributed equally to this work with: Kari Kuulasmaa, Heribert Schunkert

  Affiliation Universität zu Lübeck, Lübeck, Germany

  ⨯
• [ view all ]
• [ view less ]